The store will not work correctly when cookies are disabled.
(R)-9-hydroxy-1,2,3-trimethoxy-5-methyl-11,12-dihydro-5H-benzo[e]cyclohepta[c]oxepin-10(7H)-one
ID: ALA4761501
PubChem CID: 62706886
Max Phase: Preclinical
Molecular Formula: C19H22O6
Molecular Weight: 346.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(c(OC)c1OC)C1=C(C=C(O)C(=O)CC1)CO[C@@H]2C
Standard InChI: InChI=1S/C19H22O6/c1-10-13-8-16(22-2)18(23-3)19(24-4)17(13)12-5-6-14(20)15(21)7-11(12)9-25-10/h7-8,10,21H,5-6,9H2,1-4H3/t10-/m1/s1
Standard InChI Key: YTHQSGHKJQQWKT-SNVBAGLBSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
8.9561 -9.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7485 -9.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3081 -9.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6024 -9.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3965 -9.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8925 -9.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5970 -10.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3164 -8.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4089 -10.7349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1117 -8.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8925 -8.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9561 -11.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7609 -11.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6106 -7.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9561 -7.7468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1435 -11.0857 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7526 -7.9367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6024 -10.2892 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1908 -9.4802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1908 -7.8376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8925 -10.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4810 -9.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1826 -7.0163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9434 -12.0474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7806 -6.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 3 1 0
5 2 1 0
6 4 2 0
7 1 1 0
8 3 2 0
9 5 2 0
10 2 1 0
11 14 2 0
12 7 1 0
13 12 1 0
14 8 1 0
15 8 1 0
16 9 1 0
17 10 1 0
18 4 1 0
19 6 1 0
20 11 1 0
21 18 1 0
22 19 1 0
23 20 1 0
9 13 1 0
15 17 1 0
11 6 1 0
13 24 2 0
15 25 1 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.38 | Molecular Weight (Monoisotopic): 346.1416 | AlogP: 3.36 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.50 | CX Basic pKa: ┄ | CX LogP: 1.87 | CX LogD: 1.83 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.90 | Np Likeness Score: 1.21 |
References
1. Gracheva IA,Shchegravina ES,Schmalz HG,Beletskaya IP,Fedorov AY. (2020) Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives., 63 (19.0): [PMID:32432867] [10.1021/acs.jmedchem.0c00222] |